Market Trends of Global Cranial Implants Industry
Customized Cranial Implants is Expected to Register Significant Growth During the Forecast Period
Customized cranial implants are made to fit the precise size, shape, and features of a patient's skull. These implants are made utilizing medical imaging technologies to build a three-dimensional (3D) model of the patient's skull, such as computed tomography (CT) scans or magnetic resonance imaging (MRI). A personalized implant to fit the patient's unique anatomy and needs is then produced using the 3D model. Customized cranial implants are used to treat various conditions, including traumatic brain injuries, tumors, and congenital defects.
Customized cranial implants are expected to account for a significant share of the market in the forecasted period owing to factors such as their ability to meet the patient's specific needs by customizing the implants based on injuries or defects, thereby reducing the risk of infection and rising product approvals.
Increased research and developments have been carried out to improve the customization of cranial implants, which boosts market growth. For instance, the article published in Scientific Reports in April 2024 stated that the application of superplastic forming (SPF) and single point incremental forming (SPIF) methods for the production of highly customized cranial Ti-6AL-4V ELI prostheses implants intended for cranial reconstructions revealed valuable insights. It was found that areas adjacent to the center of the cranial defect displayed the greatest levels of immature bone, which was characterized by increased porosity, reduced trabecular thickness, and broader trabecular spacing. Hence, with such advantages associated with customized cranial implants, the market is expected to experience significant growth during the forecast period.
Moreover, the emergence of numerous companies and their growing strategies such as, mergers, acquisitions, and the introduction of new products, contribute significantly to the expansion of the market. For instance, in April 2024, 3D Systems received 510(k) clearance from the Food and Drug Administration (FDA) for its patient-specific VSP PEEK Cranial Implant, which is 3D printed. The ability to create customized PEEK cranial plates holds great promise for incorporating 3D printing into standard clinical practice. Hence, such initiatives taken by prominent players are projected to drive market growth during the forecast period.
North America is Expected to Hold a Significant Share in the Market Over the Forecast Period
The geographical analysis of the cranial implants market shows that North America holds a significant market share in the global market. North America has been the primary market for cranial implants, owing to the rise in brain tumor cases and the adoption of advanced technologies. For instance, as per the Brain Tumor Statistics provided by the ASCO, in March 2023, an estimated 24,810 adults in the United States were diagnosed with primary cancerous tumors of the brain and spinal cord by the end of 2023. As per the same source, an estimated 5,230 children under the age of 20 were diagnosed with a CNS tumor in the United States in 2023. Hence, the high prevalence of brain tumors needs surgery, which is likely to create a high demand for cranial implants in the region during the forecast period.
Furthermore, prominent regional players and increased product launches with notable results and usage are other factors responsible for high market growth in the North American region. For instance, in August 2024, Longeviti Neuro Solutions secured a pioneering patent for its innovative translucent cranial implant, the ClearFit, in the United States. This advanced implant combines brain-computer interface (BCI) technology, brain mapping capabilities, and neuro sonography (brain ultrasound). With this groundbreaking development, the cranial implant establishes a new benchmark in neurosurgical procedures, which is expected to boost the market growth in the region over the forecast period.
Hence, North America is expected to register significant growth during the forecast period due to the factors mentioned above, such as the high burden of brain tumors coupled with surgeries and prominent results from newly launched products.
